logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Lates News

date
10/05/2025
UBS maintains its rating on Celldex Therapeutics (CLDX.US) and adjusts its rating from Buy to Buy, with a target price adjusted from $44.00 to $38.00.
Latest
2 m ago
Shanghai Central Meteorological Observatory issues a blue warning for strong winds.
5 m ago
G7 foreign ministers issue joint statement calling on India and Pakistan to exercise restraint.
9 m ago
National Bureau of Statistics: CPI slightly decreased year on year, mainly affected by the downward trend in international oil prices.
11 m ago
Dong Lijuan: In April 2025, the month-on-month CPI turned from a decline to an increase, and the core CPI growth remained stable.
12 m ago
National Bureau of Statistics: The month-on-month decline in PPI continues to be the same as last month, with prices in some industrial sectors showing a steady and positive trend.
See all latestmore
logo
Contact US
qr
+852 - 60190728
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.